Drug Trial Radar · NCT07563881
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
333
Planned (sponsor's estimate)
Start
Jun 5, 2026
Primary completion
Jul 2029
Study completion Sep 2029
Sponsor
- Lead sponsor
- Rapport Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- May 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.
Conditions
- Focal Seizure
- Epilepsy
- Focal Epilepsy
Interventions
RAP-219Drug
RAP-219 high dose tablets administered orally daily
RAP-219Drug
RAP-219 medium dose tablets administered orally daily
PlaceboOther
Matching placebo tablets administered orally daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Percent Change in Seizure FrequencyTime frame: End of double-blind treatment period (end of week 14) vs Baseline
Locations
24 sites in 4 countries. Site status is shown where the registry gives one.
Clinical Study Center
Birmingham, Alabama · Recruiting
Clinical Study Center
Palmdale, California · Recruiting
Clinical Study Center
San Francisco, California · Recruiting
Clinical Study Center
Gulf Breeze, Florida · Recruiting
Clinical Study Center
Atlanta, Georgia · Recruiting
Clinical Study Center
Boise, Idaho · Recruiting
Clinical Study Center
Springfield, Illinois · Recruiting
Clinical Study Center
Fort Wayne, Indiana · Recruiting
Clinical Study Center
Bethesda, Maryland · Recruiting
Clinical Study Center
Hackensack, New Jersey · Recruiting
Clinical Study Center
Livingston, New Jersey · Recruiting
Clinical Study Center
New York, New York · Recruiting
Clinical Study Center
The Bronx, New York · Recruiting
Clinical Study Center
Asheville, North Carolina · Recruiting
Clinical Study Center
Cleveland, Ohio · Recruiting
Clinical Study Center
Philadelphia, Pennsylvania · Recruiting
Clinical Study Center
Richmond, Virginia · Recruiting
Clinical Study Center
Melbourne, Australia · Recruiting
Clinical Study Center
Sydney, Australia · Recruiting
Clinical Study Center
Seoul, South Korea · Recruiting
Clinical Study Center
Busan, Republic of Korea, South Korea · Recruiting
Clinical Study Center
Seoul, Republic of Korea, South Korea · Recruiting
Clinical Study Center
Seoul, Republic of Korea, South Korea · Recruiting
Clinical Study Center
Plymouth, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.